期刊文献+

SIRT1启动子表达调控载体的构建和活性分析及AML1-ETO对其转录活性的影响 被引量:2

Construction of SIRT1 Promoter Expression Vector and Its Activity Analysis as well as Influence of AML1-ET0 on Transcriptional Regulation of SIRT1 Gene
在线阅读 下载PDF
导出
摘要 目的:本研究旨在分析AML1-ETO阳性白血病中SIRT1基因的表达及调控机理,寻找SIRT1核心启动子区域。方法:利用实时定量PCR方法在AML1-ETO阳性白血病细胞株和白血病临床样本中研究SIRT1基因的表达情况;构建SIRT1基因启动子-荧光素酶报告载体,分析其在293T细胞中的活性。采用PCR方法从含有SIRT1基因转录起始位点5'区的基因片段中扩增SIRT1基因核心启动子序列,插入经XhoⅠ和HindⅢ双酶切的荧光素酶报告载体p GL3-Basic,采用阳离子脂质体Super Fect包裹荧光素酶报告重组子转染293T细胞,应用双荧光素酶检测试剂盒测定荧光素酶活性。采用双荧光素酶报告基因检测方法,研究AML1-ETO对SIRT1启动子转录活性的调节作用。结果:AML1-ETO的表达与SIRT1的表达呈正相关;成功构建了6种SIRT1基因序列的荧光素酶报告重组子,并通过了酶切以及基因测序方法的鉴定;荧光素酶报告重组子在293T细胞中的荧光素酶活性明显高于阴性对照,明确了SIRT1基因核心启动子位置;研究结果证明融合蛋白AML1-ETO可以正向调控SIRT1启动子活性,SIRT1对AML1-ETO阳性白血病发生发展的影响。研究表明:SIRT1可能是AML1-ETO的靶基因之一。结论:成功构建了SIRT1基因启动子-荧光素酶报告载体,找到了SIRT1基因核心启动子区,且核心启动子在293T细胞中有较高的活性。AML1-ETO通过促进SIRT1启动子的活性对其进行转录调控。 Objective : This study was aimed to analyze the expression and regulation mechanism of SIRT1 in AML1 - ETO positive leukemia to find the core promoter. Methods :The real-time RT-PCR was used to detect the expression of SIRT1 in AML1-ETO positive leukemia cell line and clinical samples of leukemia patients, a S1RT1 promoter-luciferase reporter vector was constructed and the promoter activity was evaluated in the 293T cell line. A series of possible core promoter fragments of the SIRT1 5 '-untranslated region were amplified by PCR, the PCR products were cloned into Xho I/Hind^I-digested pGL3-Basic reporter vector, the poly-cationic compound SuperFect reporter vector complexes were transfected into 293T cells. The dual-luciferase Reporter Assay System was used to quantitate the reporter vector luciferase activity. Results: The six kinds of promoter fragment of SIRT1 gene were successfully constructed and cloned into the pGL3-Basic reporter vector, which was authenticated by Xho I/Hind 111 co-digestion and DNA sequencing. The luciferase activity of the promoter construct was significantly higher than that of the pGL3-Basic promoter in 293T cells. The luciferase report gene assay was also used to detect the regulation of AML1-ETO on the transcription activity of SIRT1 promoter. The results showed that the expression level of SIRT1 increased with the increase mens of AML1-ETO, the promoter of SIRT1 could be bound by AML1-ETO. Conclusion:The SIRT1 promoter-luciferase reporter vector is successfully constructed, the transfection system used in this study can effectively transferene in 293T cells. The SIRT1 core promoter possesses higher activity in 293T cells and can promote significantly expression of luciferase reporter gene in 293T cells. The transcription regulation of AML1-ETO on SIRT1 is carded out via promoting its promoter activity.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第1期12-18,共7页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目(30800482 81270610 81170518 30971297) 北京市科技新星计划项目(2011114) 北京市自然科学基金(7132217) 军队高新技术项目(2010gxjs091)
关键词 SIRT1基因 荧光素酶报告基因 基因表达调控 基因转染 转录调控 AML1-ETO阳性白血病 SIRT1 gene Luciferase reporter gene gene expression regulation gene transfection trans-regulation AML1-ET0 positive leukemia
作者简介 窦立萍,副主任医师,副教授.E-mail:lipingruirui@163.com 共同通讯作者:于力,主任医师,教授,博士生导师.E-mail:chunhuiliyu@yahoo.com;
  • 相关文献

参考文献12

  • 1Licht J D.AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21)AML.Oncogene,2001;20(40):5660.
  • 2Peterson LF,Zhang DE.The 8;21 translocation in leukemogenesis.Oncogene,2004;23(24):4255-4262.
  • 3Balkhi MY,Christopeit M,Chen Y,et al.AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.Exp Hematol,2008;36(11):1449-1460.e1.
  • 4Peterson LF,Yan M,Zhang DE.The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21)fusion protein AML1-ETO.Blood,2007;109(10):4392-4398.
  • 5Araki T,Sasaki Y,Milbrandt J.Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.Science,2004;305(5686):1010-1013.
  • 6朱琦.AML1-ETO融合基因和白血病[J].国外医学(输血及血液学分册),2000,23(6):315-318. 被引量:1
  • 7Bitterman KJ,Anderson RM,Cohen HY,et al.Inhibition of silencing and accelerated aging by nicotinamide,a putative negative regulator of yeast sir2 and human SIRT1.J Biol Chem,2002;277(47):45099-45107.
  • 8Lagouge M,Argmann C,Gerhart-Hines Z,et al.Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α.Cell,2006;127(6):1109-1122.
  • 9Cha EJ,Noh SJ,Kwon KS,et al.Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.Clin Cancer Res,2009;15(13):4453-4459.
  • 10Stünkel W,Peh BK,Tan YC,et al.Function of the SIRT1 protein deacetylase in cancer.Biotechnology journal,2007;2(11):1360-1368.

二级参考文献33

  • 1Cimino G, Cenfra N, Elia L, et al. The therapeutic response and clinical outcome of adults with ALL1 (MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. Haematologica, 2010 ; 95 (5) : 837 - 840.
  • 2Li Q, Frestedt JL, Kersey JH. AF4 encodes a ubiquitous protein that in both native and mll-af4 fusion types localizes to subnuclear compartments. Blood, 1998; 92(10): 3841 -3847.
  • 3Liu H, Cheng EH, Hsieh JJ. MLL fusions: pathways to leukemia. Cancer Biol Ther, 2009 ; 8 ( 13 ) : 1204 - 1211.
  • 4Maitta RW, Cannizzaro LA, Ramesh KH. Association of MLL amplification with poor outcome in acute myeloid leukemia. Cancer Genet Cytogenet, 2009 ; 192 ( 1 ) : 40 - 43.
  • 5Yamaguchi H, Hanawa H, Uchida N, et al. Multistep patho- genesis of leukemia via the mll-af4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression. Exp Hematol, 2009 ; 37 (6) : 701 - 714.
  • 6Ju X, Li D, Shi Q, et al. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatr Hematol Oncol, 2009 ; 26 ( 1 ) : I - 10.
  • 7Liu Q, Fu H, Sun F, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res, 2008; 36(16) : 5391 -5404.
  • 8BitterMA,LeBeauMM,RowleyJD,etal.HumPathol,1987,18:211
  • 9SunW,O'ConnellM,SpeckNA.JVirol,1993,67:1976
  • 10NorthT,GuTL,StacyT,etal.Blood,1998,92(Suppl1):570a

共引文献3

同被引文献35

  • 1宋玉溪,赵新利.蛹虫草的研究开发进展[J].河南农业,2007(21):44-44. 被引量:5
  • 2宋金俤,刘超,华秀红,林金盛.蛹虫草产业化栽培瓶颈及其对策[J].中国食用菌,2009,28(1):62-64. 被引量:19
  • 3中华人民共和国卫生部公告(2009年 第3号)[J].中华人民共和国卫生部公报,2009(5):21-22. 被引量:6
  • 4Ling Li,Lisheng Wang,Liang Li,Zhiqiang Wang,Yinwei Ho,Tinisha McDonald,Tessa L. Holyoake,WenYong Chen,Ravi Bhatia.Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib[J]. Cancer Cell . 2012 (2)
  • 5Joost H.A. Martens,Arie B. Brinkman,Femke Simmer,Kees-Jan Francoijs,Angela Nebbioso,Felicetto Ferrara,Lucia Altucci,Hendrik G. Stunnenberg.PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia[J]. Cancer Cell . 2010 (2)
  • 6Sasca D,Hahnel PS,Szybinski J,et al.SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood . 2014
  • 7Grisolano Jay L,O’Neal Julie,Cain Jennifer,Tomasson Michael H.An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. Proceedings of the National Academy of Sciences of the United States of America . 2003
  • 8Duvic Madeleine,Talpur Rakshandra,Ni Xiao,Zhang Chunlei,Hazarika Parul,Kelly Cecilia,Chiao Judy H,Reilly John F,Ricker Justin L,Richon Victoria M,Frankel Stanley R.Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood . 2006
  • 9Elise A. Olsen,Youn H. Kim,Timothy M. Kuzel,Theresa R. Pacheco,Francine M. Foss,Sareeta Parker,Stanley R. Frankel,Cong Chen,Justin L. Ricker,Jean Marie Arduino,Madeleine Duv.Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma. Japanese Journal of Clinical Oncology . 2007
  • 10Jang Kyu Yun,Hwang Sung Ho,Kwon Keun Sang,Kim Kyung Ryoul,Choi Ha Na,Lee Na-Ri,Kwak Jae-Yong,Park Byung-Hyun,Park Ho Sung,Chung Myoung Ja,Kang Myoung Jae,Lee Dong Geun,Kim Hun Soo,Shim Hyeok,Moon Woo Sung.SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. The American journal of surgical pathology . 2008

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部